Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04046952 · ClinicalTrials.gov registry record · NA

Comparing TR Band to Statseal in Conjunction With TR Band II

A NA study, sponsored by VA Long Beach Healthcare System.

Terminated
Registry status
NA
Development phase
443
Enrollment target

NCT04046952 is a NA study that was terminated before completion, run by VA Long Beach Healthcare System. The registered enrollment target is 443 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04046952, a NA study, was terminated before completion, sponsored by VA Long Beach Healthcare System.

TERMINATED
Registry status
NA
Development phase
443 participants
Enrollment target

Study Summary

The purpose of this clinical study is to compare how well two different devices for achieving hemostasis perform in patients undergoing transradial procedures. Both devices are approved by the FDA for this use, and have already been used by clinicians on patients undergoing transradial procedures. It is believed that the use of both devices in combination compared to the hemostasis band (TR band) alone will shorten the time that it takes to 'seal' the artery, resulting in a shorter period of time that you would need to wear the hemostasis band.

Interventions

  • DEVICE Statseal with TR Band
  • DEVICE TR band only

Trial Details

FieldValue
Enrollment Target 443 participants
Start Date 2019-10-10
Est. Completion 2020-12-15
Phase NA

Sponsor

VA Long Beach Healthcare System

2 total trials

What the Registry Record Tells You About NCT04046952

The ClinicalTrials.gov registry entry for NCT04046952 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 443 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Long Beach Healthcare System, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Statseal with TR Band is the first listed.

NCT04046952 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04046952 about?

NCT04046952 is a clinical study titled "Comparing TR Band to Statseal in Conjunction With TR Band II". The purpose of this clinical study is to compare how well two different devices for achieving hemostasis perform in patients undergoing transradial procedures. Both devices are approved by the FDA for this use, and have already been used by clinicians on patients undergoing transradial procedures. I...

What is the current status of trial NCT04046952?

This trial is currently terminated. It is a NA study. The enrollment target is 443 participants. The study started on 2019-10-10. Estimated completion is 2020-12-15.

What interventions are being tested in trial NCT04046952?

The interventions under investigation include: Statseal with TR Band (DEVICE), TR band only (DEVICE).

Who is sponsoring clinical trial NCT04046952?

This trial is sponsored by VA Long Beach Healthcare System, which has 2 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.